Anzeige
Mehr »
Login
Mittwoch, 05.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Geheime Erdgas-Perle: Horizon Petroleum startet Lachowice-Projekt: Aktie vor neuem Höhenflug?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JPMY | ISIN: US64131A1051 | Ticker-Symbol: NRC
Tradegate
04.02.25
19:41 Uhr
3,400 Euro
+0,065
+1,95 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEURONETICS INC Chart 1 Jahr
5-Tage-Chart
NEURONETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,2503,35517:57
3,2803,32517:54

Aktuelle News zur NEURONETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiNeuronetics, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
NEURONETICS Aktie jetzt für 0€ handeln
DiWhy Neuronetics Inc (STIM) Is Skyrocketing So Far In 20252
29.01.Neuronetics: NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression10
13.01.Neuronetics prognostiziert Umsatzwachstum und Kosteneinsparungen nach Übernahme18
13.01.Neuronetics Provides Business Update and Issues 2025 Guidance52Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as of December 9, 2024Expects full year 2025 pro forma...
► Artikel lesen
13.01.Neuronetics, Inc. - 8-K, Current Report1
16.12.24Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)148MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company") today announced the granting of inducement awards to new employees as described below. In accordance...
► Artikel lesen
10.12.24Neuronetics, Inc. - 8-K, Current Report-
10.12.24Neuronetics and Greenbrook TMS Announce Closing of Transaction49MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook", and together with Neuronetics,...
► Artikel lesen
15.11.24Greenbrook TMS Inc.: Greenbrook Receives Final Court Approval For Arrangement With Neuronetics17TORONTO, Nov. 15, 2024 /CNW/ - Greenbrook TMS Inc. (OTC: GBNHF) ("Greenbrook" or the "Company") is pleased to announce that the Company has obtained a final order...
► Artikel lesen
13.11.24Neuronetics, Inc. - 8-K, Current Report-
12.11.24Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)71MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
12.11.24Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results170MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics") a commercial stage medical technology company with a strategic vision of transforming...
► Artikel lesen
11.11.24Greenbrook Shareholders Approve Arrangement With Neuronetics1
01.11.24Neuronetics extends Madryn registration rights period8
01.11.24Neuronetics, Inc. - 8-K, Current Report3
14.10.24Neuronetics: NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression4
04.10.24Neuronetics and Greenbrook TMS get interim order for merger3
04.10.24Greenbrook TMS Inc.: Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings63MALVERN, Pa. and TORONTO, Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior...
► Artikel lesen
02.10.24Neuronetics, Inc. - 8-K, Current Report3
Seite:  Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1